Skip to content

Clinical value of electroultrasonic instrument in the treatment of intrauterine adhesions and changes of related protein expression

Clinical value of electroultrasonic instrument in the treatment of intrauterine adhesions and changes of related protein expression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058901
Enrollment
Unknown
Registered
2022-04-19
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesion

Interventions

Electroultrasonic combined with estrogen group:Electroultrasonic combined with estrogen and progesterone therapy
Estrogen progesterone group:Estrogen and progesterone therapy

Sponsors

Reproductive Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-40 years; 2. Patients who were diagnosed as intrauterine adhesions by hysteroscopy and planned to undergo intrauterine adhesions separation; 3. Volunteer and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute and subacute genital inflammation and pelvic infection; 2. Repair of uterine perforation within 6 months; 3. Cervical cancer, adenomyosis, hysteromyoma (non submucous) > 4cm, endometrial cancer and other uterine tumors; 4. Tuberculosis of reproductive tract without anti tuberculosis treatment; 5. Suffering from serious diseases: such as heart, lung, liver, kidney and other medical diseases, coagulation dysfunction and bleeding diseases, which are difficult to tolerate surgery; 6. Have taken hormone drugs in the past month; 7. Endocrine related diseases (such as ovarian hypofunction and thyroid disease); 8. Patients with moderate and severe intrauterine adhesions after two or more times of intrauterine adhesions release.

Design outcomes

Primary

MeasureTime frame
9/5000 Clinical efficiency of uterine cavity recovery;Endometrial receptivity under ultrasound;

Secondary

MeasureTime frame
Menstrual quantity;Microvascular density of endometrial tissue;Vascular endothelial growth factor;Endometrial tissue integrin familyavß3;Endometrial morphology, gland count and fibrotic area ratio;Clinical pregnancy rate;Recurrence rate of intrauterine adhesion;

Countries

China

Contacts

Public ContactSi en Mo

Reproductive Hospital of Guangxi Zhuang Autonomous Region

380231941@qq.com+86 13100512627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026